-
Je něco špatně v tomto záznamu ?
Effect of procathepsin D activation peptide on gene expression of breast cancer cells
Benes P, Vashishta A, Saraswat-Ohri S, Fusek M, Pospisilova S, Tichy B, Vetvicka V.
Jazyk angličtina Země Irsko
Grantová podpora
NR8448
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- financování organizované MeSH
- kathepsin D farmakologie MeSH
- lidé MeSH
- nádorové buňky kultivované MeSH
- nádorové proteiny genetika MeSH
- nádory prsu genetika MeSH
- NF-kappa B - podjednotka p52 genetika metabolismus MeSH
- peptidové fragmenty farmakologie MeSH
- polymerázová řetězová reakce s reverzní transkripcí MeSH
- prekurzory enzymů farmakologie MeSH
- regulace genové exprese u nádorů účinky léků MeSH
- sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů MeSH
- signální transdukce MeSH
- stanovení celkové genové exprese MeSH
- Check Tag
- lidé MeSH
Overexpression of procathepsin D (pCD) is reported to occur in numerous types of cancer and is associated with increased growth and metastasis. It has been established that pCD affects multiple stages of tumor progression including proliferation, angiogenesis and metastasis. Previously, we showed that the mitogenic effect of pCD on cancer cells is mediated by interaction of its activation peptide (AP) with yet unidentified cell surface receptor. In this investigation, gene expression profiles were compared between AP-treated and control human breast cancer ZR-75-1 cells to elucidate the mechanism of AP mitogenicity. Several differentially expressed genes involved in signal transduction, regulation of cell cycle, apoptosis, tumor invasion and metastasis were identified using microarray technology. These findings, including overexpression of NF-kappaB2, were confirmed in breast cancer cell lines by reverse-transcriptase PCR (RT-PCR). Understanding the mechanism of pCDs effect on breast cancer cells could extend possibilities of breast cancer treatment in the future.
Citace poskytuje Crossref.org
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07522650
- 003
- CZ-PrNML
- 005
- 20131002135920.0
- 008
- 090506s2006 ie e eng||
- 009
- AR
- 024 __
- $a 10.1016/j.canlet.2005.07.030 $2 doi
- 035 __
- $a (PubMed)16168559
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Beneš, Petr. $7 xx0208982
- 245 10
- $a Effect of procathepsin D activation peptide on gene expression of breast cancer cells / $c Benes P, Vashishta A, Saraswat-Ohri S, Fusek M, Pospisilova S, Tichy B, Vetvicka V.
- 314 __
- $a Department of Genetics and Molecular Biology, Faculty of Science, Masaryk University Brno, Kotlarska 2, Brno 61137, Czech Republic. pbenes@sci.muni.cz
- 520 9_
- $a Overexpression of procathepsin D (pCD) is reported to occur in numerous types of cancer and is associated with increased growth and metastasis. It has been established that pCD affects multiple stages of tumor progression including proliferation, angiogenesis and metastasis. Previously, we showed that the mitogenic effect of pCD on cancer cells is mediated by interaction of its activation peptide (AP) with yet unidentified cell surface receptor. In this investigation, gene expression profiles were compared between AP-treated and control human breast cancer ZR-75-1 cells to elucidate the mechanism of AP mitogenicity. Several differentially expressed genes involved in signal transduction, regulation of cell cycle, apoptosis, tumor invasion and metastasis were identified using microarray technology. These findings, including overexpression of NF-kappaB2, were confirmed in breast cancer cell lines by reverse-transcriptase PCR (RT-PCR). Understanding the mechanism of pCDs effect on breast cancer cells could extend possibilities of breast cancer treatment in the future.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a nádory prsu $x genetika $7 D001943
- 650 _2
- $a kathepsin D $x farmakologie $7 D002402
- 650 _2
- $a prekurzory enzymů $x farmakologie $7 D004792
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a regulace genové exprese u nádorů $x účinky léků $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a NF-kappa B - podjednotka p52 $x genetika $x metabolismus $7 D052003
- 650 _2
- $a nádorové proteiny $x genetika $7 D009363
- 650 _2
- $a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
- 650 _2
- $a peptidové fragmenty $x farmakologie $7 D010446
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 700 1_
- $a Vashishta, Aruna
- 700 1_
- $a Saraswat, Ohri Sujata
- 700 1_
- $a Fusek, Martin, $d 1958- $7 jo2007286435
- 700 1_
- $a Pospíšilová, Šárka, $d 1969- $7 xx0101843
- 700 1_
- $a Tichý, Boris. $7 xx0312236
- 700 1_
- $a Větvička, Václav, $d 1954- $7 skuk0001572
- 773 0_
- $w MED00001044 $t Cancer letters $g Roč. 239, č. 1 (2006), s. 46-54 $x 0304-3835
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20131002140437 $b ABA008
- 999 __
- $a ok $b bmc $g 650742 $s 503905
- BAS __
- $a 3
- BMC __
- $a 2006 $b 239 $c 1 $d 46-54 $i 0304-3835 $m Cancer letters $x MED00001044
- GRA __
- $a NR8448 $p MZ0
- LZP __
- $a 2009-B3/ipme